[1]JournalofChemicalResearch,Miniprint,1984,p.771-795
[2]JournalofMedicinalChemistry,2004,vol.47,p.6666-6668
[3]Patent:US2004/242883,2004,A1
[4]Patent:WO2004/48386,2004,A2.Locationinpatent:Page79
117390-39-3
117390-36-0
83179-01-5
96516-52-8
1372924-05-4
957035-17-5 | 3,4-Dichloro-2-methylphenylboronic acid | AA006BPQ | MFCD09475873
90533-23-6 | 4-(3-Chlorophenyl)thiazol-2-amine | AA006CM1 | MFCD02664012
690632-72-5 | 5-Bromo-2,3-dihydrobenzo[b]furan-7-boronic acid | AA006DGK | MFCD06200893
936939-85-4 | 1-(1,5-Dimethyl-1h-pyrazol-4-yl)ethanamine | AA006EKH | MFCD03422568
909910-43-6 | A 83-01 | AA006FP7 | MFCD08705403
68850-10-2 | Cyclopropanecarboxylic acid, 2-ethyl- | AA006GEQ | MFCD16744654
92534-73-1 | 4-Amino-1-methyl-1h-pyrazole-5-carboxamide | AA006H15 | MFCD00464001
90151-04-5 | 4-Hydroxy-2-nitrobenzaldehyde | AA006IAN | MFCD18397317
672309-93-2 | N-(4'-Carboxylic)benzoyl-4-piperidone | AA006JLL | MFCD00798179
91527-90-1 | (3-Methyl-4-nitrophenyl)hydrazine | AA006LAS | MFCD04108576